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Determination of in vitro postantibiotic effects in 
Staphylococcus auveus and Eschevichia coli by 
[3H] thymidine incorporation 
Magnhs Gottjiedssonl, Helga Erlendsddttirl, Adnls te inn Gudmundssofz '  
and Sigurdur G u d m u n d s s o n * ~ ~ ~ ~  
Departments of 'Clinical Microbiology and 21nternal Medicine, Borgarspitalinn (Reykjavik City 
Hospital), and 3University of Iceland, Faculty of Medicine, Reykjavik, Iceland 
Postantibiotic effects (PAE) and control-related effective regrowth time (CERT) of dicloxacillin, vancomycin, rifampin and 
gentamicin in  Staphylococcus aureus and imipenem, gentamicin, tobramycin, doxycycline and rifampin in Escherichia 
coli were measured by standard viability counting and L3H]thymidine incorporation. For PAE determination, the two 
methods correlated well; r2=0.821 for S. aureus and r2=0.939 for E. coli. For viable counts below the detection limits 
of lo5 to lo6 loglo CFU/mL, the PAE was overestimated by the [3Hlthymidine method. Quantitation of CERT by both 
methods showed a good correlation, r2=0.867 for S. aureus and r2=0.997 for E. coli. Measuring L3Hlthymidine 
incorporation in bacteria is a novel alternative method for the determination of PAE and CERT. 
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INTRODUCTION 
The postantibiotic effect (PAE), the period of growth 
suppression after short exposure to antibiotics, is a 
feature of several organism-antibiotic combinations 
[1,21. The clinical relevance of the PAE pertains to its 
impact on antimicrobial dosing, where drugs inducing 
long PAEs may be administered with longer dosing 
intervals than currently employed without loss of 
efficacy [2]. This has been demonstrated in clinical 
medicine with once-daily dosing of aminoglycosides 
The standard method of PAE determination by 
viability counting [2] i s  rather time-consuming and 
tedious, and various alternative methods have therefore 
been devised. They include the bioluminescence assay 
of intracellular ATP [6-9], measurements of optical 
[3-51. 
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density [lo-121, electrical impedance 1131, and COIF 
ductance [14]. Furthermore, bacterial morphology, 
as estimated by microscopy [15] or electron microscopy 
1161 or automatically, employing a Coulter counter 
[17], has also been used for PAE measurements. We 
have previously described a novel method where PAE 
was quantitated by measuring bacterial COr generation 
Control-related effective regrowth time (CEKT) 
is a combined pharmacodynamic parameter which 
incorporates both bacterial kill and PAE. While for 
some antibiotic-organism combinations the duration 
of PAE has been shown to be variable depending on 
the method used, there is some evidence that values for 
CERT may be less method dependent [19]. 
The purpose of this study was to evaluate whether 
['Hlthymidine incorporation could be used for PAE 
and CERT determination in vitro as compared to the 
standard method of viability counting. 
[181. 
MATERIALS AND METHODS 
Organisms and media 
The organisms used in the study were Eschevichia coli 
ATCC 25922 and Staphylococcus aureus ATCC 25923. 
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Mueller-Hinton broth (MHB, Difco Laboratories, 
Detroit, Michigan) served as culture medium. 
Antibiotics and chemicals 
Rifampin was supplied by Ciba-Geigy (Basel, 
Switzerland), doxycycline by Delta (HafnarfjJijrdur, 
Iceland), gentamicin by Roussel Laboratories Ltd 
(Uxbridge, UK), imipenem by Merck Sharp & Dohme 
International (Rahway, New Jersey, USA), dicloxacillin 
by Bristol Sermoneta (Latina, Italy), and tobramycin 
and vancomycin by Eli Lilly & Co. (Indianapolis, 
Indiana, USA). Stock solutions were prepared in 
sterile saline except iniipeiiem and rifampin, for which 
phosphate-buffered saline and methanol were used, 
respectively. Fresh stock solutions were prepared daily 
for imipenem and rifampin but stored at -2OOC until 
use for other antimicrobials. Minimum inhibitory 
concentrations (MICs) were determined by a standard 
microtiter dilution method [20]. 
6-[”H]thymidine (specific activity 5.0 Ci/mmol) 
was purchased from Amersham International (Amer- 
sham, UK) and trichloroacetic acid (TCA) from 
Merck (Merck, Darrnstadt, Germany). Toluene with 
5 g of 2,2’-p-phenylen-bis-(phenyloxazol) (POPOP) 
and 0.12 g of 2,5-diphenyloxazol (PPO) (Merck) per 
liter served as scintillation fluid. 
lnoculum and organism-antibiotic combinations 
Before each experiment, three to four colonies of the 
test organism were transferred to 5 mL of MHB, 
diluted serially after 6-8 h of growth and grown 
overnight at 35.5 O C .  Subsequently, the culture was 
adjusted to an inoculum of -10’ CFU/mL in the 
logarithmic phase of growth. The [3H]thymidine in- 
corporation was studied in each organism after 1 h of 
exposure to the following antibiotics (concentration in 
multiples of MIC): S. atfreus after exposure to dicloxa- 
cillin ( 2 ~ ,  4x and 8x MIC), gentamicin (2x MIC), 
vancomycin ( 2 ~  and 4~ MIC) and rifampin ( 2 ~  and 
4 X  MIC), and E.  coli after exposure to gentamicin 
(0.5x, I X  and 2 x  MIC), tobramycin (2x MIC), 
doxycycline (4x and 8x MIC), rifampin ( 2 ~  and 4~ 
MIC), and imipenem (1x and 2 x  MIC). 
Drug removal 
After 1 h of exposure to antibiotics, the bacterial 
culture was diluted 100-fold in fresh prewarmed MHB 
in order to remove the antibiotics. This frequently 
resulted in bacterial counts equal to or less than lo3 
CFU/mL in experiments with very bactericidal drugs. 
This proved to be below the threshold of detection for 
[3H]thymidine incorporation, and as a result DNA 
synthesis was difficult to quantitate in these experi- 
ments. In order to get higher bacterial counts in some 
of the experiments the drug was removed by filtration 
of the culture through filters with 0.45 pm pore size 
(Millipore HA, Millipore Corporation, Bedford, MA). 
The filters were washed with 100 mL of sterile 0.9% 
NaC1, followed by 10 mL of MHB. Subsequently, the 
filter was placed in fresh, prewarmed MHB, shaken 
vigorously for 2 min and removed. The unexposed 
control organisms were processed in the same manner. 
[3H]thymidine incorporation 
A modified method ofEngle et al. was used [21]. After 
the drug removal procedure, 1 niL of each of the E.  coli 
and S. aweus cultures was pulsed at 1.5 h intervals with 
10 pCi 6-[3H]tliymidine for exactly 10 min. 
The bacteria were then lysed with ice-cold TCA, 
final concentration 10% w/v. The lysed bacteria were 
transferred to tissue culture microtiter plates, 200 pl in 
each well at each time point in tri- o r  quadruplicate. 
The suspension was then harvested with a cell 
harvester (Titertekm, Skatron, Norway) on glass filters 
and each well washed carefully with 10 mL of sterile 
water. The glass filters were air-dried for several hours 
and the radioactivity determined with a 1214 P-liquid 
scintillation counter (LICE@’, Wallac, Turku, Finland). 
The counts per minute were used as an indicator 
of rate of [3H] thymidine incorporation at the time 
points. Correction was made for background radio- 
activity. Viable counts were estimated at 1.5-h intervals 
by serial dilution in ice-cold 0.9% NaCl and plating on 
M H  agar. 
Initial studies revealed that [”HI thymidine incor- 
poration was unmeasurable if the number of viable 
bacteria was <4 loglo(CFU/niL). Thus, experiments 
with lower post-drug removal inocula are not included 
in the analysis of data for PAE determination. 
PAE 
The duration of the PAE determined by viable counts 
(PAE,,) was calculated using the equation PAE = 
T - C, where C is the time required by control 
organisms to grow 1 loglo CFU/mL, and Tis the time 
necessary for antibiotic-treated bacteria to increase 
by 1 loglo CFU/mL after drug removal [2]. For 
[‘Hlthymidine incorporation, the was similarly 
defined as the difference in time for radioactivity of 
antibiotic-treated and control organisms to increase 
1 loglo counts/miii. 
CERT 
The duration of the CERT determined by viable 
counts was defined as CERT = T - C, where C is the 
time needed for the control to grow 1 loglo CFU/rnL 
after drug removal, and T represents the time taken for 
the exposed culture to reach the same viable count. For 
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CERT determined by ["Hlthymidine incorporation, 
the same definition was used, with C being the time 
needed for the control to increase 1 loglo counts/min 
after drug removal and T representing the time needed 
for the exposed culture to reach the same radioactivity. 
Analysis of data 
The counts per minute values from the triplicates or 
quadruplicates were averaged. The correlation between 
the two different methods of PAE nieasurements was 
calculated by least-squares linear regression. 
RESULTS 
For E.  roli ATCC 25922 the MICs were: gentamicin 
1 .O mg/L, tobraniycin 2.0 mg/L, iniipeneni 0.125 
nig/L, rifarnpin 16 mg/L and doxycycline 2.0 mg/L. 
For S. azmus ATCC 25923 the MICs were: gentaniicin 
0.125 mg/L, dicloxacillin 0.25 mg/L, vancomycin 1 .0 
mg/L, and rifampin 0.015 mg/L. 
An example of a typical experiment involving 
growth curves and countdmin for E.  coli after 1 h 
of exposure to doxycycline, 4xMIC, is presented in 
Figure 1. 
Comparison of duration of the PAE measured by 
the two methods after different antibiotics is shown 
in Figure 2 for S. atireus and Figure 3 for E. coli. The 
correlation coefficients for the relationship between 
10 
- 10 a 
E -. 
3 
0 
- 
10 
10 
10 " 10 
0 90 180 270 
Time (rnin) after drug removal 
PAE,, and PAE,I, were r2=0 .821  (p=O.OOOl) for S. 
aweus and r'=0.939 (p<0.0001) for E. coli. For 
S. u u w a  the regression line had an intercept of -0.03 
and a slope of 0.76 k 0.25 (95% confidence intervals 
[CI]) and for E. coli the regression line had an intercept 
of 0.53 and a slope of1 -07 2 0.13 (95% CI) . The slopes 
were not statistically different from a slope of 1 .i). If the 
two methods were equivalent in determining the PAE, 
the slope would be 1.0 with an intercept of 0. 
However, certain differences between the two 
methods were evident. As shown in Figure 2, the ['HI 
thymidine incorporation method showed a tendency to 
underestimate the PAE for S.  nureus by 0.5 k 0.5 h 
(mean TL 95% CI). In contrast. the PAE was over- 
estimated in E. roli by this method (Figure 3) by 0.8 ? 
1.1 h (mean k 95% CI). The detection threshold of the 
[3H] thymidine incorporation method was close to 1 Os 
CFU/mL for S. auyeus and 106 CFU/niL for G. d i .  
For each log,(, CFU/mL below these limits, 50-60 niin 
were added to the value obtained by the standard 
method. A good correlation was demonstrated between 
the degree of over- or underestiniation by the ['HI 
thymidine incorporation method and loglo CFU/inL 
after drug removal (r2=0.684 [ p  <0.005] arid r2=0.X76 
[p<0.005] for S. aureus and E. r d i ,  respectively). 
A comparison of the two niethods for deter- 
mination of CERT is shown in Figure 4. As shown, the 
two methods correlated well, with ~ ~ 4 . 8 6 7  (slope 
10.936, intercept = -0.3 2) for S .  a u m s  and v'=0.997 
E4 PAE viable counts 
Figure 1 Exainples of growth (CFU/niL) arid [-3H] 
thymidine incorporation (counts/min) curves of E. coli 
ATCC 25922. Circles, uncxpoced control organisms; 
triangles, organisms during PAE after exposure to 
doxycyclin 4x MIC for I 11. Closed symbols, viability 
counts (log~o(CFU/niL)); open symbols, ['HI thymidine 
incorporation (counts/niin). In the example, the PAE 
deterniined by viable counts was 1.2 h and by ['HI 
thymidine incorporation 1.6 h. 
Antibiotics 
(concentration in  multides of MIC) 
Figure 2 Comparison of the ['HI thymidine incorporation 
method and viability counting for PAE determination in 
S. a t w u s .  Bacterial counts post-drug removal were > lo4 
CFU/mL (range: 2.5 x 104 to 6 X l o 5  CFU/niL). 
Columns represent means from two to three experiments. 
Bars represent range. Di, dicloxacillin; Ge, gentaniicin; 
Va, vancomycin; Rif, rifainpin. a: data from one experinicnt. 
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Figure 3 Comparison of the [3H]thymidine incorporation 
method and viability counting for PAE determination in 
E. coli. Bacterial counts post-drug removal were >lo" 
CFU/mL (range: 1.5 X lo4 to 2.3 X lo6 CFU/niL). 
Columns represent means from two to three experiments. 
Bars represent range. Ge, gentamicin; To, tobramycin; 
Dx, doxycycline; Rif, rifampin; Im, imipenem. 
(slope =0.979, intercept = -0.11) for E. coli. The 
duration of the CERT was similar irrespective of the 
method used: 2.6 f 1.2 (mean i SD by viable counts) 
and 2.3 i 1.2 (mean 2 SD by ['Hlthymidine) for 
5'. uureus, and 3.4 k 3.0 (mean rL SD by viable counts) 
and 3.2 ? 3.0 (mean f SD by ["Hlthymidine) for 
E. coli. 
DISCUSSION 
Previously, we have demonstrated a good correlation 
between ['Hlthymidine incorporation and viable counts 
in a growing culture of S. aureus and E. coli [22]. In 
this study good correlation was demonstrated between 
the method of ["]thymidine incorporation for 
determination of the duration of the PAE and the 
'gold-standard' of viable counts. 
However, as compared to the PAEs quantitated by 
viable counts, the PAEs quantitated by ['Hlthymidine 
incorporation were usually underestimated for S. aureus 
(Figure 2) and overestimated for E. coli (Figure 3), but 
by less than 3 h; these inaccuracies are thus not likely 
to have serious consequences for screening. 
O n  the other hand, a different discrepancy became 
evident regarding the rate of uptake of ['Hlthymidine 
between species, dependent on the bacterial count after 
drug removal. The detection limits of the method was 
5 loglo CFU/mL for S.  aureus and 6 loglo CFU/inL for 
E.  coli. For each loglo CFU/mL below these numbers, 
the duration of the PAE was overestimated by 50-60 
min as measured by the [3H]thymidine incorporation 
method, probably representing the time needed for the 
organisms to reach sufficient biomass. The reasons for 
the different detection limits for S.  nureus and E. coli are 
obscure, but may relate to differences in intracellular 
amounts of thymidine between species, variation in the 
rate of ['Hlthymidine uptake [22] or differences in 
bioniass/CFU ratio between species. Furthermore, we 
have previously shown that patterns of bacterial DNA 
synthesis during PAE are different depending on the 
antibiotics, which might explain the differences in PAE 
determined by the two methods reported here [22]. 
A number of alternative methods have been em- 
ployed for quantitation of the PAE [23]. Studies 
employing the bioluminescence assay of intracellular 
bacterial ATP have produced equivocal results: values 
both similar to and three to four times higher than 
the ones obtained by viable counts [6-91, depending 
on the organism-antibiotic combination. Moreover, 
the bactericidal action of antibiotics is frequently 
Underestimated by this method, possibly due to the 
contribution of dead, still intact bacteria to the ATP 
level [6], leading to longer PA?% An advantage of the 
['HI thymidine incorporation method is that unlysed 
dead bacteria do not incorporate ['Hlthymidine but 
may still contain intracellular ATP and contribute to 
optical density. 
PAE determinations by optical density compared 
well with viable counts after exposure of E. coli to three 
antibiotics [l 11. However, the threshold of detection 
for this method was high, approximating 6.7 loglo 
CFU/mL [12]. Using conductance for determination 
of PAE, the threshold of sensitivity was shown to be 
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Figure 4 Correlation between CERT in S. au~eus and E. 
coli as determined by viability counting and ["HI thymidine 
incorporation. Closed circles: E. coli; open circles: S. aweus. 
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close to lo5 CFU/mL [14], which is similar to the 
sensitivity of the ['Hlthymidine method. 
CERT is a combined pharmacodynamic variable 
representing the sum of bacterial kill and PAE. Other 
studies have demonstrated good correlation between 
CERT measured by bioluniinescence of ATP and 
viable counts, despite poor correlation of the two 
methods for PAE determination [ 191. Our findings 
suggest that ['HI thymidine incorporation may also be 
of use for measuring CERT. 
In this study, a good concordance was observed 
between the PAEs and CERTs of selected antibiotics, 
whether measured by viable counts or by [3H]thy- 
niidine incorporation. Thus, measuring these variables 
by ['HI thymidine incorporation is an alternative, less 
laborious method than the conventional method of 
viable counts. If all facilities are at  hand, the results can 
be obtained 2 h after the end of growth suppression. 
For determination of PAE, bacterial counts exceeding 
lo4 CFU/mL are generally required after drug removal, 
significantly lower than for measurements of optical 
density and impedance. Pulsing the bacterial culture 
with ['Hlthymidine at 1.5-h intervals seems sufficient 
for PAE estimation. The results can thus be obtained 
by three to five pulsations for most antibiotics. Apart 
from these practical considerations, measuring the PAE 
of suitable organisms by [3H]thyniidine incorporation 
gives additional information on metabolic activity in 
the growth-suppressed bacteria not obtainable by the 
conventional method of viable counts [22]. 
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